HOME > TOP STORIES
TOP STORIES
-
ORGANIZATION Wholesalers to Address Product Return Issue after Fake Harvoni Case: JPWA Chair
March 28, 2017
-
ORGANIZATION Vaccine Association to Standardize Presentation of Expiration Dates above Inspection Dates on Outer Packaging
March 27, 2017
-
BUSINESS Wholesale Dealer President Deeply Sorry for Letting Fake Harvoni into Supply Chain
March 24, 2017
-
TRENDS As Takeda’s R&D Rejig Progresses, Biotech JV Launch Sets Direction for Its Japan Regime
March 23, 2017
-
BUSINESS Japan Begins Using PD-L1 Expression Biomarker for Immune Checkpoint Inhibitors, but Challenges Linger
March 22, 2017
-
ORGANIZATION Study Group Presents Proposal for Future Vision for Kampo Medicines
March 21, 2017
-
BUSINESS Court Finds Data Manipulation, but Not False Advertising: Diovan Case
March 17, 2017
-
BUSINESS Novartis, Ex-Employee Found Not Guilty in Diovan Case
March 16, 2017
-
REGULATORY Chuikyo Begins Debate on Gap-Year Price Revisions; Industry Frets Advance Announcement of Discrepancy Threshold
March 16, 2017
-
BUSINESS Takeda Biotech JV to Focus on 8 Projects for Now, Eyes IPO: CEO Okumura
March 15, 2017
-
REGULATORY Celgene Faces Biz Improvement Order over Delays in Side Effect Reporting
March 15, 2017
-
BUSINESS INCJ, Takeda, Medipal to Form Biotech Venture
March 14, 2017
-
BUSINESS 1st Line Use, Administration Interval Will Be Key Differentiator for Keytruda: MSD Japan Chief
March 14, 2017
-
REGULATORY Tokyo, Osaka Govts Issue Biz Improvement Order to Dealers over Fake Harvoni
March 14, 2017
-
REGULATORY Reference Pricing on Agenda for CEFP Social Security Working Group
March 10, 2017
-
BUSINESS Pfizer’s FY2016 Japan Sales Slide 7.4% on Price Cuts, Generic Erosions
March 9, 2017
-
REGULATORY MHLW to Set Up Panel on Drug Distribution after Fake Harvoni Flub, Eyes GDP Ordinance
March 8, 2017
-
REGULATORY Tap Real-World Data for Optimal Use of High-Priced Meds: MHLW Bureau Chief
March 7, 2017
-
COMMENTARY Growing Hopes for Control of Hepatic Cancer; Road to Cures for Hepatitis B, NASH Might Be in Sight
March 7, 2017
-
INTERVIEW Chugai to Execute Area-Based Strategy Centering on General Reps: Marketing Chief
March 6, 2017
ページ
The traditional HR Business Partner (HRBP) model, once the gold standard for HR delivery, is undergoing a significant transformation. Many organizations, particularly in industries like pharmaceuticals, are moving towards a more agile resource model, aiming to streamline HR operations and…
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…
The Ministry of Health, Labor and Welfare (MHLW) posted the final report compiled by its pharmaceutical regulation panel on its website on April 24, providing cases of drugs that could be exempted from all-case post marketing surveillance (PMS).The MHLW plans…